These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12877639)

  • 1. An evaluation of current shigellosis treatment.
    Bhattacharya SK; Sur D
    Expert Opin Pharmacother; 2003 Aug; 4(8):1315-20. PubMed ID: 12877639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shigellosis.
    Niyogi SK
    J Microbiol; 2005 Apr; 43(2):133-43. PubMed ID: 15880088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shigellosis : challenges & management issues.
    Sur D; Ramamurthy T; Deen J; Bhattacharya SK
    Indian J Med Res; 2004 Nov; 120(5):454-62. PubMed ID: 15591629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of shigellosis in Lagos, Nigeria: trends in antimicrobial resistance.
    Iwalokun BA; Gbenle GO; Smith SI; Ogunledun A; Akinsinde KA; Omonigbehin EA
    J Health Popul Nutr; 2001 Sep; 19(3):183-90. PubMed ID: 11761772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shigella isolates of Nepal: changes in the incidence of shigella subgroups and trends of antimicrobial susceptibility pattern.
    Kansakar P; Malla S; Ghimire GR
    Kathmandu Univ Med J (KUMJ); 2007; 5(1):32-7. PubMed ID: 18603983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shigellosis in Calcutta during 1990-1992: antibiotic susceptibility pattern and clinical features.
    Bhattacharya MK; Bhattacharya SK; Paul M; Dutta D; Dutta P; Kole H; De D; Ghosh AR; Das P; Nair GB
    J Diarrhoeal Dis Res; 1994 Jun; 12(2):121-4. PubMed ID: 7963341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial.
    Khan WA; Seas C; Dhar U; Salam MA; Bennish ML
    Ann Intern Med; 1997 May; 126(9):697-703. PubMed ID: 9139555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial resistance and serotypes of Shigella isolates in Kigali, Rwanda (1983 to 1993): increasing frequency of multiple resistance.
    Bogaerts J; Verhaegen J; Munyabikali JP; Mukantabana B; Lemmens P; Vandeven J; Vandepitte J
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):165-71. PubMed ID: 9327243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shigella in Africa: New Insights From the Vaccine Impact on Diarrhea in Africa (VIDA) Study.
    Kasumba IN; Badji H; Powell H; Hossain MJ; Omore R; Sow SO; Verani JR; Platts-Mills JA; Widdowson MA; Zaman SMA; Jones J; Sen S; Permala-Booth J; Nasrin S; Roose A; Nasrin D; Ochieng JB; Juma J; Doh S; Jones JCM; Antonio M; Awuor AO; Sugerman CE; Watson N; Focht C; Liu J; Houpt E; Kotloff KL; Tennant SM
    Clin Infect Dis; 2023 Apr; 76(76 Suppl1):S66-S76. PubMed ID: 37074444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased susceptibility to antimicrobials among Shigella flexneri isolates in Manipal, South India--a 5 year hospital based study.
    Mamatha B; Rituparna C
    Southeast Asian J Trop Med Public Health; 2012 Nov; 43(6):1447-51. PubMed ID: 23413708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial resistance among Shigella in New Zealand.
    Heffernan H; Woodhouse R; Hewison C; Sherwood J
    N Z Med J; 2018 Jun; 131(1477):56-62. PubMed ID: 29927916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increasing incidence of antibiotic resistance in shigellas from humans in England and Wales: recommendations for therapy.
    Cheasty T; Skinner JA; Rowe B; Threlfall EJ
    Microb Drug Resist; 1998; 4(1):57-60. PubMed ID: 9533726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotics in the management of shigellosis in children: what role for the quinolones?
    Fontaine O
    Rev Infect Dis; 1989; 11 Suppl 5():S1145-50. PubMed ID: 2672246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Evaluation of High Fluoroquinolone Resistant Genes in Endemic Cases of Shigellosis, Northeast Part of Karnataka, India.
    C P; Desai P; R KC
    Ann Glob Health; 2016; 82(5):832-839. PubMed ID: 28283137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial therapy for shigellosis.
    Salam MA; Bennish ML
    Rev Infect Dis; 1991; 13 Suppl 4():S332-41. PubMed ID: 2047659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to antimicrobial therapy for shigellosis in Thailand.
    Lolekha S; Vibulbandhitkit S; Poonyarit P
    Rev Infect Dis; 1991; 13 Suppl 4():S342-6. PubMed ID: 2047660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species diversity and antimicrobial resistance of Shigella spp. isolated between 2001 and 2004 from hospitalized children with diarrhoea in Kolkata (Calcutta), India.
    Pazhani GP; Ramamurthy T; Mitra U; Bhattacharya SK; Niyogi SK
    Epidemiol Infect; 2005 Dec; 133(6):1089-95. PubMed ID: 16274506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Shigellosis or bacillary dysentery].
    Nicolas X; Granier H; Le Guen P
    Presse Med; 2007 Nov; 36(11 Pt 2):1606-18. PubMed ID: 17399943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of isolation of shigella serogroups/serotypes and their antimicrobial susceptibility pattern in children from slum areas in Karachi.
    Zafar A; Sabir N; Bhutta ZA
    J Pak Med Assoc; 2005 May; 55(5):184-8. PubMed ID: 15960281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoroquinolones-resistant Shigella species in Iranian children: a meta-analysis.
    Khademi F; Sahebkar A
    World J Pediatr; 2019 Oct; 15(5):441-453. PubMed ID: 31154582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.